FdaApplication
NDA 216993
Identifiers
- fda_app_no: NDA216993
Properties
| Property | Value |
|---|---|
| applicant_name | DAIICHI SANKYO INC |
| application_type | NDA |
| approval_date | 2023-07-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VANFLYTA | QUIZARTINIB DIHYDROCHLORIDE | EQ 26.5MG BASE | TABLET;ORAL |
| VANFLYTA | QUIZARTINIB DIHYDROCHLORIDE | EQ 17.7MG BASE | TABLET;ORAL |
2 products